Assessing hypothyroidism in elderly patients after TAVI
Hypothyroidism After the TAVI Procedure in Elderly Patients
This study looks at how common hypothyroidism is in older patients after they have a heart valve replacement procedure and what factors might contribute to it.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 70 Years and up |
| Sex | All |
| Sponsor | Universitair Ziekenhuis Brussel Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Brussels) |
| Trial ID | NCT04831957 on ClinicalTrials.gov |
What this trial studies
This study evaluates the incidence and predictive factors of hypothyroidism in elderly patients who undergo trans-catheter aortic valve replacement (TAVI) for aortic stenosis. It aims to assess thyroid function before and after the TAVI procedure, considering factors such as underlying thyroid disease and medication use. The study will also explore how the occurrence of hypothyroidism affects geriatric assessments in these patients. By understanding these dynamics, the study seeks to improve patient outcomes following TAVI.
Who should consider this trial
Good fit: Ideal candidates for this study are males and females aged 70 years and older who are scheduled to undergo a TAVI procedure.
Not a fit: Patients with known thyroid dysfunction or those receiving specific medications like lithium or recent radio-iodine treatment may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better management of thyroid function in elderly patients undergoing TAVI, potentially improving their overall health outcomes.
How similar studies have performed: While the approach of assessing thyroid function post-TAVI is relatively novel, similar studies have indicated the importance of monitoring thyroid health in elderly patients undergoing major procedures.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Provision of signed and dated, written Informed Consent prior to any study specific proce-dures * Patient: males and females must be ≥ 70 years old * Patients who will undergo a TAVI procedure Exclusion Criteria: * \- No obtained signed, dated and written Informed Consent. * Known thyroid dysfunction (for example: Basedow, Hashimoto,...) * Patients receiving any of the following: Lithium, Strumazol or a recent treatment of radio-Iode
Where this trial is running
Brussels
- UZ brussel — Brussels, Belgium (Recruiting)
Study contacts
- Study coordinator: nathalie Compté, Dr, PhD
- Email: nath_compte@hotmail.com
- Phone: 024749159
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.